Basma M. El Sharazly
Mefloquine loaded niosomes as a promising approach for the treatment of acute and chronic toxoplasmosis
El Sharazly, Basma M.; Aboul Asaad, Ibrahim A.; Yassen, Nabila A.; El Maghraby, Gamal M.; Carter, Wayne G.; Mohamed, Dareen A.; Amer, Basma S.; Ismail, Howaida I.H.
Authors
Ibrahim A. Aboul Asaad
Nabila A. Yassen
Gamal M. El Maghraby
Dr WAYNE CARTER WAYNE.CARTER@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Dareen A. Mohamed
Basma S. Amer
Howaida I.H. Ismail
Abstract
Toxoplasmosis is a disease with a worldwide distribution and significant morbidity and mortality. In search of effective treatment, mefloquine (MQ) was repurposed and loaded with niosomes to treat acute and chronic phases of toxoplasmosis in experimental mice. Mice were orally inoculated with 20 cysts of Toxoplasma gondii (ME 49 strain) for the acute model of infection and 10 cysts for the chronic model of infection. Infected mice were dosed with MQ solution or MQ-niosomes at 50 mg/kg/day, starting from the second day post-infection (PI) (acute model) or the fifth week PI (chronic model), and this was continued for six consecutive days. The effects of MQ solution and MQ-niosomes were compared with a pyrimethamine/sulfadiazine (PYR/SDZ) dosing combination as mortality rates, brain cyst number, inflammatory score, and immunohistochemical studies that included an estimation of apoptotic cells (TUNEL assays). In the acute infection model, MQ solution and MQ-niosomes significantly reduced the mortality rate from 45% to 25 and 10%, respectively, compared with infected untreated controls, and decreased the number of brain cysts by 51.5% and 66.9%, respectively. In the chronic infection model, cyst reduction reached 80.9% and 12.3% for MQ solution and MQ-niosomes treatments, respectively. MQ-niosomes significantly decreased inflammation induced by acute or chronic T. gondii infection. Additionally, immunohistochemical analysis revealed that MQ solution and MQ-niosomes significantly increased the number of TUNEL-positive cells in brain tissue, indicative of induction of apoptosis. Collectively, these results indicate that MQ-niosomes may provide a useful delivery strategy to treat both acute and chronic toxoplasmosis.
Citation
El Sharazly, B. M., Aboul Asaad, I. A., Yassen, N. A., El Maghraby, G. M., Carter, W. G., Mohamed, D. A., Amer, B. S., & Ismail, H. I. (2023). Mefloquine loaded niosomes as a promising approach for the treatment of acute and chronic toxoplasmosis. Acta Tropica, 239, Article 106810. https://doi.org/10.1016/j.actatropica.2022.106810
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 25, 2022 |
Online Publication Date | Dec 26, 2022 |
Publication Date | 2023-03 |
Deposit Date | Jan 5, 2023 |
Publicly Available Date | Dec 27, 2023 |
Journal | Acta Tropica |
Print ISSN | 0001-706X |
Electronic ISSN | 1873-6254 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 239 |
Article Number | 106810 |
DOI | https://doi.org/10.1016/j.actatropica.2022.106810 |
Keywords | Infectious Diseases; Parasitology; Insect Science; Veterinary (miscellaneous) |
Public URL | https://nottingham-repository.worktribe.com/output/15715422 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0001706X22005010?via%3Dihub |
Files
revised manuscript Basma El Sharazly et al 2022 accepted
(241 Kb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search